Mutations in exon 2 of MED12 were identified in 39% (14 of 36) of LM tumor specimens, and the ACLY gene was mutated in 6% (two of 36) of LM tumor specimens (Data Supplement). This evidence concerns the gene MED12 and neoplasm.